U.S. signs $5.9 billion deal with Pfizer for COVID-19 treatment pill
The U.S. authorities can pay drugmaker Pfizer practically $5.3 billion for 10 million treatment programs of its potential COVID-19 treatment if regulators approve it. Pfizer requested...